Rgenta Therapeutics

formerly Rgenta

Rgenta Therapeutics is a biotech company in Cambridge, United States, founded in 2018. It has raised $70.0M across 2 rounds, most recently a $52.0M Series A in November 2022.

Oral small-molecule RNA-targeting medicines for oncology and neurological disorders

Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$70.0M
Last Round
$52.0M Series ANov 2022
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 1 investor for this company. The full record is or through the API.

About

Rgenta Therapeutics is a clinical-stage biopharmaceutical company developing oral, small-molecule RNA-targeting medicines focused on oncology and neurological disorders. The company applies a proprietary platform that uses genomic data to identify high-impact RNA target sites, then selects molecules from specialized compound libraries designed to engage those sites and RNA-binding regulatory proteins. By modulating RNA function with high specificity, Rgenta aims to prevent the production of disease-associated proteins and unlock therapies for previously 'undruggable' targets. Its lead program, RGT-61159, is advancing through clinical trials.

Summary

It lists 11–50 employees. It has raised $70.0M in total across 2 rounds, most recently a $52.0M Series A round in Nov 2022. Investors include Delos Capital.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries ANov 2022
$52.0M

Sign up to see all 2 events

Funding: Extension Round through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Rgenta Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/rgenta-therapeutics"><img src="https://indexed.vc/api/badge/company/rgenta-therapeutics" alt="Rgenta Therapeutics on Indexed.vc" width="260" height="76" /></a>